Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fas and Fas ligand as prognostic factors in human breast carcinoma.

Medical science monitor : international medical journal of experimental and clinical research - 1 Nov 2006

Bebenek Marek, Duś Danuta, Koźlak Joanna

Abstract excerpt

BACKGROUND: Several studies on breast cancer patients indicate that Fas/FasL status may have a significant impact on patient survival, but their conclusions are still controversial. The aim of this study was to determine the prognostic value of Fas and Fas ligand (FasL) expressions in the early s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma
Share to Fas Ligand Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fas Receptor

Share to Gene Expression Regulation, Neoplastic

Share to Lymphatic Metastasis

Share to Receptors, Estrogen

Share to Time Factors

Source

Identifiers

PMID: 17072269

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17072269-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Fas and Fas ligand as prognostic factors in human breast carcinoma.PMID 17072269Read ↗

Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy.Semantic proximity Read ↗

Expression of FAS (CD95/APO-1) and FAS ligand in lung cancer, its prognostic and predictive relevanceSemantic proximity Read ↗

Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.Semantic proximity Read ↗

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.Semantic proximity Read ↗

Fas receptor-mediated apoptosis: a clinical application?Semantic proximity Read ↗

Fas ligand expression in BRCA1-associated hereditary breast carcinoma clearly differs from that in sporadic breast carcinoma.Semantic proximity Read ↗

A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.Semantic proximity Read ↗

Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).Semantic proximity Read ↗

Regression of Human Breast Carcinoma in Nude Mice After Ad <i>sflt</i> Gene Therapy is Mediated by Tumor Vascular Endothelial Cell ApoptosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.